AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters
AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…
Erytech Pharma Granted Australia Patent Titled ‘Arginine Deiminase Encapsulated Inside Erythrocytes And Their Use In Treating Cancer’
https://twitter.com/US_Patent_Plays/status/1544744441755353091
NeuroMetrix Granted European Patent ‘Smart Electrode Assembly For Transcutaneous Electrical Nerve Stimulation’
https://twitter.com/PatentGrants/status/1544740557804580864
Global Coalition For Adaptive Research, Biohaven, And Vigeo Announce Commencement Of Biohaven’s Troriluzole And Vigeo’s VT1021 In GBM AGILE Trial
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial
Biohaven and Vigeo Now Enrolling in GBM AGILE, Registrational
This Analyst Believes Precigen’s Non-Healthcare Divesture Removes Financial Overhang
Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS.
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today
NYC Healthy Tweets ‘Monkeypox vaccine doses have arrived in NYC! We plan to make appointments available starting
https://twitter.com/nycHealthy/status/1544693903407955968
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. …
Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants
Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing. IMM-BCP-01…
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: